Lipid peroxidation and total cholesterol in HAART-naïve patients infected with circulating recombinant forms of human immunodeficiency virus type-1 in Cameroon.

Lipid peroxidation and total cholesterol in HAART-naïve patients infected with circulating recombinant forms of human immunodeficiency virus type-1 in Cameroon.

<h4>Background</h4>HIV infection has commonly been found to affect lipid profile and antioxidant defense.<h4>Objectives</h4>To determine the effects of Human Immunodeficiency Virus (HIV) infection and viral subtype on patient's cholesterol and oxidative stress markers, a...

Full description

Bibliographic Details
Main Authors:	Georges Teto, Georgette D Kanmogne, Judith N Torimiro, George Alemnji, Flore N Nguemaim, Désiré Takou, Aubin Nanfack, Asonganyi Tazoacha
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23762297/?tool=EBI

Similar Items

Genetic characterization of Trypanosoma brucei gambiense isolates from Cameroon
by: Kanmogne, Georgette Djuidje
Published: (1996)

Prevalence of Hypertension in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) Compared with HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon.
by: Christian Akem Dimala, et al.
Published: (2016-01-01)

Characterization of human immunodeficiency virus type 1 and host genetic determinants of infection in Cameroon rural inhabitants
by: Torimiro, Judith Ndongo
Published: (2004)

A Comparison of the Diabetes Risk Score in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) and HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon.
by: Christian Akem Dimala, et al.
Published: (2016-01-01)

Genetic variability and drug resistance mutations in HIV-1 infected individuals on HAART or drug naïve in Limbe, Cameroon
by: Agyingi L, et al.
Published: (2012-09-01)

Functional changes of the vasculature in HIV/AIDS patients on Haart and Haart Naïve HIV participants
by: Awotedu, Kofoworola Olajire
Published: (2013)

Thrombocytopenia according to antiretroviral drug combinations, viremia and CD4 lymphocytes among HIV-infected patients in Cameroon: a snapshot from the City of Yaoundé
by: Alex Durand Nka, et al.
Published: (2019-09-01)

Lipopolysaccharide biosynthesis in Pseudomonas aeruginosa
by: Asonganyi, Tazoacha Michael
Published: (1979)

Genotypic prediction of tropism of highly diverse HIV-1 strains from Cameroon.
by: Christelle Mbondji-Wonje, et al.
Published: (2014-01-01)

Human immunodeficiency virus type 1 ((HIV-1) subtypes in the northwest region, Cameroon
by: Lem Edith Abongwa, et al.
Published: (2019-08-01)

Anemia and risk factors in HAART naïve and HAART experienced HIV positive persons in south west Ethiopia: a comparative study.
by: Lealem Gedefaw, et al.
Published: (2013-01-01)

HIV-1 drug resistance testing is essential for heavily-treated patients switching from first- to second-line regimens in resource-limited settings: evidence from routine clinical practice in Cameroon
by: Desire Takou, et al.
Published: (2019-03-01)

Ophthalmic manifestations of human immunodeficiency virus infection: Pre- highly active antiretroviral chemotherapy (HAART) and post- HAART era
by: Sinha Rajesh, et al.
Published: (2008-01-01)

Molecular and Genetic Characterization of HIV-1 Tat Exon-1 Gene from Cameroon Shows Conserved Tat HLA-Binding Epitopes: Functional Implications
by: Georges Teto, et al.
Published: (2016-07-01)

Lipodystrophy in Human Immunodeficiency Virus (HIV) Patients on Highly Active Antiretroviral Therapy (Haart)
by: N. Sunil Kumar, et al.
Published: (2015-07-01)

Pre-treatment drug resistance and HIV-1 genetic diversity in the rural and urban settings of Northwest-Cameroon.
by: Joseph Fokam, et al.
Published: (2020-01-01)

Prévalence des trypanosomoses des animaux domestiques dans le foyer de la maladie du sommeil de Fontem au Cameroun
by: Tazoacha Asonganyi, et al.
Published: (1990-01-01)

Immuno-virological response and clinical outcome in naive elderly patients treated with antiretroviral therapy (HAART)
by: Palermo F, et al.
Published: (2010-05-01)

The Effect of Arthrospira platensis Capsules on CD4 T-Cells and Antioxidative Capacity in a Randomized Pilot Study of Adult Women Infected with Human Immunodeficiency Virus Not under HAART in Yaoundé, Cameroon
by: Frank Stéphane Winter, et al.
Published: (2014-07-01)

Malignancies in human immunodeficiency virus infected patients in India: Initial experience in the HAART era
by: Surendra K Sharma, et al.
Published: (2015-01-01)

Programmatic and Individual-level Factors Associated with CD4 Cell Count at HAART Initiation and Survival Among Treatment-naïve Patients Initiating HAART in sub-Saharan Africa.
by: Eduardo, Eduard
Published: (2014)

Pharmacokinetic Considerations for Selection of HAART in Treatment-Naive HIV-Infected Individuals, 2008: More Than it Seems?
by: Andrew D. Luber PharmD
Published: (2008-03-01)

Rates of HBV, HCV, HDV and HIV type 1 among pregnant women and HIV type 1 drug resistance-associated mutations in breastfeeding women on antiretroviral therapy
by: Judith N. Torimiro, et al.
Published: (2018-12-01)

Spatial variation of soil weathering processes in the tropical high reliefs of Cameroon (Central Africa)
by: Désiré Tsozué, et al.
Published: (2020-04-01)

Genesis and classification of soils developed on gabbro in the high reliefs of Maroua region, North Cameroon
by: Désiré Tsozué, et al.
Published: (2017-04-01)

Intestinal parasitosis in relation to CD4+T cells levels and anemia among HAART initiated and HAART naive pediatric HIV patients in a Model ART center in Addis Ababa, Ethiopia.
by: Hylemariam Mihiretie Mengist, et al.
Published: (2015-01-01)

Factors impacting early mortality in tuberculosis/HIV patients: differences between subjects naïve to and previously started on HAART.
by: Carolina Arana Stanis Schmaltz, et al.
Published: (2012-01-01)

Renal outcome in human immunodeficiency virus (HIV) infected patients on highly active antiretroviral therapy (HAART)
by: Sinyiza, Frank Watson
Published: (2016)

Naïve T Cells in Immunosuppression Diseases: Human Immunodeficiency Virus and Cytomegalovirus
by: Kent Wijaya Setiawan, et al.
Published: (2018-03-01)

Aboriginal status is a prognostic factor for mortality among antiretroviral naïve HIV-positive individuals first initiating HAART
by: Daniel Mark, et al.
Published: (2006-05-01)

Emergence of Exhausted B Cells in Asymptomatic HIV-1-Infected Patients Naïve for HAART is Related to Reduced Immune Surveillance
by: Manuela Fogli, et al.
Published: (2012-01-01)

Effects of medical male circumcision (MC) on plasma HIV viral load in HIV+ HAART naïve men; Rakai, Uganda.
by: Godfrey Kigozi, et al.
Published: (2014-01-01)

Serum Micronutrient Status of Haart-Naïve, HIV Infected Children in South Western Nigeria: A Case Controlled Study
by: H. C. Anyabolu, et al.
Published: (2014-01-01)

The neuropsychological and behavioural profiles of HIV-infected asymptomatic HAART-naïve children : a cross sectional and follow-up study
by: Webster, Victoria
Published: (2015)

Nephrotoxicity of HAART
by: Robert Kalyesubula, et al.
Published: (2011-01-01)

HAART and the liver: friend or foe?
by: Pineda JA, et al.
Published: (2010-03-01)

The KAART Trial: a randomized controlled trial of HAART compared to the combination of HAART and chemotherapy in treatment-naïve patients with HIV-associated Kaposi sarcoma (HIV-KS) in KwaZulu-Natal (KZN), South Africa
by: Aboobaker J, et al.
Published: (2010-10-01)

Preemptive therapy prevents cytomegalovirus end-organ disease in treatment-naïve patients with advanced HIV-1 infection in the HAART era.
by: Daisuke Mizushima, et al.
Published: (2013-01-01)

An evaluation of human immunodeficiency virus oral screening test awareness and preferences in the West region of Cameroon
by: Celine N. Nkenfou, et al.
Published: (2015-05-01)

Hepatitis B and C Co-Infections in Some HIV-Positive Populations in Cameroon, West Central Africa: Analysis of Samples Collected Over More Than a Decade.
by: Jean Jacques N Noubiap, et al.
Published: (2015-01-01)

Cannot write session to /tmp/vufind_sessions/sess_uvsmct7h02j8kockq3ljg3quip